RightFit Trial Directory

Parkinson's Disease clinical trials in Pittsburgh, PA

14 recruiting parkinson's disease studies with a site in Pittsburgh, PA.

All trials in Pittsburgh, PA · All Parkinson's Disease trials

RecruitingPhase 3NCT06952504

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Sponsor: Merck Sharp & Dohme LLC

Bethlehem, PA · Philadelphia, PA · +50 more sites

RecruitingPhase 3NCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca

Abington, PA · Hershey, PA · Philadelphia, PA · +60 more sites

RecruitingPhase not listedNCT03664609

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Sponsor: Boston Scientific Corporation

Pittsburgh, PA · +9 more sites

RecruitingPhase 1 / Phase 2NCT05319730

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Sponsor: Merck Sharp & Dohme LLC

Pittsburgh, PA · +4 more sites

RecruitingPhase 1 / Phase 2NCT06469944

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Sponsor: Merck Sharp & Dohme LLC

Pittsburgh, PA · +7 more sites

RecruitingPhase 3NCT07174310

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Sponsor: Hoffmann-La Roche

Philadelphia, PA · Pittsburgh, PA · +51 more sites

RecruitingPhase 2NCT06780085

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Sponsor: Merck Sharp & Dohme LLC

Pittsburgh, PA · +2 more sites

RecruitingNot applicableNCT07056361

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control

Sponsor: Jorge Gonzalez-Martinez

Pittsburgh, PA

RecruitingPhase not listedNCT04994015

Parkinson's Foundation PD GENEration Genetic Registry

Sponsor: Parkinson's Foundation

Philadelphia, PA · Pittsburgh, PA · +60 more sites

RecruitingPhase 1 / Phase 2NCT06445972

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Sponsor: Merck Sharp & Dohme LLC

Pittsburgh, PA · +7 more sites

RecruitingPhase not listedNCT04477785

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Sponsor: Michael J. Fox Foundation for Parkinson's Research

Philadelphia, PA · Pittsburgh, PA · +28 more sites

RecruitingPhase 1NCT07064005

Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Sponsor: Pravat Mandal

Pittsburgh, PA

RecruitingPhase not listedNCT04071847

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Sponsor: Abbott Medical Devices

Exton, PA · Philadelphia, PA · Pittsburgh, PA · +20 more sites

Not yet recruitingPhase 2NCT07215403

Prescriptive Infusion Algorithm (PIA)

Sponsor: AskBio Inc

Pittsburgh, PA · +3 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.